Form 483

Active Intelligence, LLC Form 483, 2024-03-08

FDA issued a Form 483 to Active Intelligence, LLC on 2024-03-08 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Active Intelligence, LLC · Cherryville, United States · Issued March 8, 2024

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

8 Mar 2024
21 CFR 211.122(d)

Label storage access limited to authorized personnel

Cited by Harshal J Desai

8 Mar 2024
21 CFR 211.166(a)

Lack of written stability program

Cited by Harshal J Desai

8 Mar 2024
21 CFR 211.180(e)

Records reviewed annually

Cited by Harshal J Desai

8 Mar 2024
21 CFR 211.80(b)

Handling and Storage to Prevent Contamination

Cited by Harshal J Desai

Inspected site

AIActive Intelligence, LLCCherryville, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.122(d)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)Cited across public-safe Form 483 observations1x
21 CFR 211.80(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere